These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma]. Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800 [TBL] [Abstract][Full Text] [Related]
34. [A case of pulmonary intravascular lymphoma treated with CHOP chemotherapy plus rituximab]. Ohkubo H; Yoshida T; Ohta K; Takaku T; Katagiri T; Paku J; Kasuga I; Minemura K; Gotoh A; Serizawa H; Mukai K; Ohyashiki K Gan To Kagaku Ryoho; 2005 Apr; 32(4):553-6. PubMed ID: 15853227 [TBL] [Abstract][Full Text] [Related]
35. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model. Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256 [TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy. Posada GarcĂa C; Florez A; Pardavila R; Garcia-Cruz A; Amador L; Alvarez M; Alberte LM; Cruces MJ Eur J Dermatol; 2009; 19(4):394-5. PubMed ID: 19467966 [No Abstract] [Full Text] [Related]
37. Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone--rituximab refractory patients. Sieniawski M; Bhartia S; Wilkinson J; Proctor SJ Leuk Lymphoma; 2009 Oct; 50(10):1726-30. PubMed ID: 19639513 [No Abstract] [Full Text] [Related]
38. Standard treatment of advanced-stage diffuse large B-cell lymphoma. Coiffier B Semin Hematol; 2006 Oct; 43(4):213-20. PubMed ID: 17027655 [TBL] [Abstract][Full Text] [Related]
39. Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma. Saito B; Shiozawa E; Usui T; Nakashima H; Maeda T; Hattori N; Shimozuma J; Adachi D; Yamochi-Onizuka T; Takimoto M; Nakamaki T; Ota H; Tomoyasu S Leukemia; 2007 Dec; 21(12):2563-6. PubMed ID: 17597802 [No Abstract] [Full Text] [Related]
40. Herpesviridae viral infections following rituximab combined chemotherapy in patients with diffuse large B-cell lymphoma. Park LC; Lee HS; Shin SH; Im H; Ye BJ; Song MK; Oh SY; Lee SM; Lee WS; Kim YS Acta Haematol; 2011; 125(4):230-6. PubMed ID: 21325812 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]